Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05206305 · ClinicalTrials.gov registry record · NA

Sensory-Evoked Cortical Gamma Oscillation

A NA study of Alzheimer Disease, sponsored by University of Tennessee Medical Center.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05206305 is a NA study of Alzheimer Disease that is actively recruiting participants, run by University of Tennessee Medical Center. The registered enrollment target is 20 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05206305, a NA study of Alzheimer Disease, is actively recruiting participants, sponsored by University of Tennessee Medical Center.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to investigate the efficacy of cortical gamma oscillation on visual sensory processing and cognitive function in Alzheimer's Disease (AD) patients by combining a therapeutic sensory stimulation device capable of evoking 40-Hz gamma oscillation via non-invasive visual and auditory stimulation with pre-established markers of cortical network activity, i.e., electroencephalography (EEG) and event-related potentials (ERP), to evaluate the applicability of the 40-Hz multimodel sensory stimulation as a novel therapeutic approach for treatment of AD patients.

Conditions Studied

Alzheimer Disease

Interventions

  • DEVICE GammaSense Stimulation device

Study Locations (1)

Tennessee

  • University of Tennessee Medical Center - Knoxville

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2022-07-01
Est. Completion 2026-06-30
Phase NA

Sponsor

University of Tennessee Medical Center

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05206305

The ClinicalTrials.gov registry entry for NCT05206305 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The listed sponsor is University of Tennessee Medical Center, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which GammaSense Stimulation device is the first listed.

NCT05206305 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT05206305 about?

NCT05206305 is a clinical study titled "Sensory-Evoked Cortical Gamma Oscillation". The purpose of the study is to investigate the efficacy of cortical gamma oscillation on visual sensory processing and cognitive function in Alzheimer's Disease (AD) patients by combining a therapeutic sensory stimulation device capable of evoking 40-Hz gamma oscillation via non-invasive visual and ...

What is the current status of trial NCT05206305?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2022-07-01. Estimated completion is 2026-06-30.

What conditions does trial NCT05206305 study?

This clinical trial studies the following conditions: Alzheimer Disease.

What interventions are being tested in trial NCT05206305?

The interventions under investigation include: GammaSense Stimulation device (DEVICE).

Who is sponsoring clinical trial NCT05206305?

This trial is sponsored by University of Tennessee Medical Center, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05206305 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alzheimer Disease

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.